AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 178 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,401,000 | +37.4% | 149,004 | +11.7% | 0.00% | – |
| Q2 2020 | $1,020,000 | -49.7% | 133,382 | -59.4% | 0.00% | -100.0% |
| Q1 2020 | $2,029,000 | -52.7% | 328,368 | -6.9% | 0.00% | -50.0% |
| Q4 2019 | $4,294,000 | -28.3% | 352,818 | -31.9% | 0.00% | 0.0% |
| Q3 2019 | $5,985,000 | -13.4% | 518,189 | -25.1% | 0.00% | -33.3% |
| Q2 2019 | $6,911,000 | – | 691,734 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,344,620 | $116,393,000 | 6.64% |
| Consonance Capital Management LP | 1,026,902 | $35,736,000 | 3.92% |
| FALCON POINT CAPITAL, LLC | 801,944 | $27,908,000 | 3.74% |
| Credit Capital Investments LLC | 72,813 | $2,534,000 | 3.24% |
| Crosspoint Capital Strategies, LLC | 99,274 | $3,455,000 | 3.07% |
| Camber Capital Management LP | 611,390 | $21,276,000 | 1.11% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 40,901 | $1,423,000 | 1.04% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 344,103 | $11,974,000 | 0.83% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 572,500 | $19,923,000 | 0.66% |
| AlphaOne Investment Services, LLC | 66,105 | $2,301,000 | 0.64% |